NAD+ telehealth providers: how to evaluate them
NAD+ is a coenzyme present in every living cell, central to mitochondrial energy production and to the activity of sirtuins and PARP enzymes involved in DNA repair. It is sold by longevity and wellness clinics as an intravenous infusion, a subcutaneous injection and an oral or sublingual supplement, marketed for energy, cognition, addiction recovery and anti-ageing.
How to evaluate a NAD+ provider
We do not publish a ranked list of NAD+ providers, for a specific reason: we have not captured and dated their pricing or verified their pharmacy relationships. Publishing a ranking we cannot substantiate would be worth less than nothing.
What we can give you is the evaluation framework we apply to the providers we have verified — the compounded GLP-1 programs in our pricing database.
| Signal | What good looks like | What should worry you |
|---|---|---|
| Prescribing clinician | Named, licensed, verifiable NPI | Unnamed 'medical team' |
| Medical evaluation | Real review; some patients are declined | A form that approves everyone |
| Pharmacy | Named facility, licence verifiable in a state board database | 'Our network of licensed pharmacies' |
| Formulation | Salt form and concentration disclosed | Will not tell you |
| Regulatory language | States plainly that compounded is not FDA-approved | 'FDA-approved pharmacy' — a meaningless phrase |
| Evidence claims | Distinguishes mechanism from demonstrated outcome | Cites mouse studies as if they were human results |
| Pricing | Total cost stated up front, cancellation terms published | Headline rate that turns out to be a first month |
Frequently asked questions
What does NAD+ cost through telehealth?
We have not verified a market price. On October 15, 2026, Oak Longevity listed NAD+ injections at $175 a month, regularly $199, a promotional price. That is one provider’s page, not a typical price. Ask any clinic for the total cost per month, including visits and supplies, in writing.
Is NAD+ FDA-approved?
No. There is no FDA-approved NAD+ drug as of October 15, 2026. NAD is in Category 1 of FDA’s interim 503A policy, so licensed pharmacies may compound it while FDA evaluates it. That is enforcement discretion, not approval or proof that it works.
Does NAD+ work?
Human studies of NAD+ injections and drips are small and short and mostly show that NAD+ levels rise. Claims about slower ageing, energy or sharper thinking rest largely on animal research. We have not re-read the literature for this update and cite no trial.
Sources
- U.S. Food and Drug Administration — approved labels and compounding guidance for this molecule.
- PubMed / NIH — indexed human clinical literature.
- ClinicalTrials.gov — registered trials, where they exist.
- Our source hierarchy and pricing-verification methodology.